Reference Identification

The development and psychometric validation of the central sensitization inventory.

Pain Practice, Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, Perez Y, Gatchel RJ. dis 2012; 12:276-285
Country: United States of America
Language: English
https://www.ncbi.nlm.nih.gov/pubmed/21951710

Other references of interest

https://pubmed.ncbi.nlm.nih.gov/35754083/

Validity of the Central Sensitization Inventory (CSI) through Rasch analysis in patients with knee osteoarthritis. 

https://onlinelibrary.wiley.com/doi/abs/10.1111/jabr.12123

This article provides an overview of CSI rationale, development, recommended uses, and research results, including evidence of validity and reliability, in clinical and non-clinical subject samples.

https://www.ncbi.nlm.nih.gov/pubmed/28851012

SLR with the objective to determine the quality of evidence these publications reported, and examine the measurement properties of the CSI.

Instrument/Tool Translations References

Cross-cultural adaptation and validity of the Spanish central sensitization inventory.

https://www.ncbi.nlm.nih.gov/pubmed/27818875

---

 Assessment of the psychometric properties of the CSI, adapted and validated for a Brazilian population (CSI-BP).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589103/

---

A systematic literature review (SLR) addressing central sensitization and central nociceptive processing in patients with rheumatoid arthritis (RA). 

https://pubmed.ncbi.nlm.nih.gov/36097821/

Salaffi F, Farah S, Mariani C, Sarzi-Puttini P, Di Carlo M. Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia. Pain Pract. 2022 Nov;22(8):702-710. doi: 10.1111/papr.13162. Epub 2022 Sep 22. PMID: 36097821; PMCID: PMC9826291.

https://www.ncbi.nlm.nih.gov/pubmed/22035625